Kanekal S - Search Results

1

Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-release gel.

Ning S, Trisler K, Brown DM, Yu NY, Kanekal S, Lundsten MJ, Knox SJ. Ning S, et al. Among authors: kanekal s. Radiother Oncol. 1996 May;39(2):179-89. doi: 10.1016/0167-8140(96)01718-5. Radiother Oncol. 1996. PMID: 8735485 Free article.

2

Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system.

Ning S, Yu N, Brown DM, Kanekal S, Knox SJ. Ning S, et al. Among authors: kanekal s. Radiother Oncol. 1999 Feb;50(2):215-23. doi: 10.1016/s0167-8140(98)00134-0. Radiother Oncol. 1999. PMID: 10368046 Free article.

3

Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts.

Smith JP, Stock E, Orenberg EK, Yu NY, Kanekal S, Brown DM. Smith JP, et al. Among authors: kanekal s. Anticancer Drugs. 1995 Dec;6(6):717-26. doi: 10.1097/00001813-199512000-00002. Anticancer Drugs. 1995. PMID: 8845483

4

Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.

Smith JP, Kanekal S, Patawaran MB, Chen JY, Jones RE, Orenberg EK, Yu NY. Smith JP, et al. Among authors: kanekal s. Cancer Chemother Pharmacol. 1999;44(4):267-74. doi: 10.1007/s002800050977. Cancer Chemother Pharmacol. 1999. PMID: 10447573

5

Storage-phosphor autoradiography: a rapid and highly sensitive method for spatial imaging and quantitation of radioisotopes.

Kanekal S, Sahai A, Jones RE, Brown D. Kanekal S, et al. J Pharmacol Toxicol Methods. 1995 Jun;33(3):171-8. doi: 10.1016/1056-8719(94)00089-m. J Pharmacol Toxicol Methods. 1995. PMID: 7640397

6

Retention of intratumor injections of cisplatinum in murine tumors and the impact on laser thermal therapy for cancer treatment.

Kanekal S, Joo J, Bublik M, Bababeygy A, Loh C, Castro DJ, Sercarz JA, Paiva MB. Kanekal S, et al. Eur Arch Otorhinolaryngol. 2009 Feb;266(2):279-84. doi: 10.1007/s00405-008-0736-3. Epub 2008 Jul 8. Eur Arch Otorhinolaryngol. 2009. PMID: 18607614

7

Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.

Mok TS, Kanekal S, Lin XR, Leung TW, Chan AT, Yeo W, Yu S, Chak K, Leavitt R, Johnson P. Mok TS, et al. Among authors: kanekal s. Cancer. 2001 Jun 15;91(12):2369-77. Cancer. 2001. PMID: 11413527

8

Circadian pharmacology of L-alanosine (SDX-102) in mice.

Li XM, Kanekal S, Crépin D, Guettier C, Carrière J, Elliott G, Lévi F. Li XM, et al. Among authors: kanekal s. Mol Cancer Ther. 2006 Feb;5(2):337-46. doi: 10.1158/1535-7163.MCT-05-0332. Mol Cancer Ther. 2006. PMID: 16505107

9

SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.

Yasui H, Hideshima T, Hamasaki M, Roccaro AM, Shiraishi N, Kumar S, Tassone P, Ishitsuka K, Raje N, Tai YT, Podar K, Chauhan D, Leoni LM, Kanekal S, Elliott G, Munshi NC, Anderson KC. Yasui H, et al. Among authors: kanekal s. Blood. 2005 Jul 15;106(2):706-12. doi: 10.1182/blood-2005-02-0838. Epub 2005 Mar 31. Blood. 2005. PMID: 15802527 Free PMC article.

10

In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.

Neri P, Yasui H, Hideshima T, Tassone P, Raje N, Catley LP, Ishitsuka K, Blotta S, Kiziltepe T, Ocio EM, Fulciniti M, Kanekal S, Elliott GT, Munshi NC, Anderson KC. Neri P, et al. Among authors: kanekal s. Br J Haematol. 2006 Jul;134(1):37-44. doi: 10.1111/j.1365-2141.2006.06122.x. Br J Haematol. 2006. PMID: 16803565 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters